Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children
Samantha M Olson,Margaret M Newhams,Natasha B Halasa,Leora R Feldstein,Tanya Novak,Scott L Weiss,Bria M Coates,Jennifer E Schuster,Adam J Schwarz,Aline B Maddux,Mark W Hall,Ryan A Nofziger,Heidi R Flori,Shira J Gertz,Michele Kong,Ronald C Sanders,Katherine Irby,Janet R Hume,Melissa L Cullimore,Steven L Shein,Neal J Thomas,Laura S Stewart,John R Barnes,Manish M Patel,Adrienne G Randolph,Pediatric Intensive Care Influenza Investigators,Kong Michele,Meghan Murdock,Glenda Hefley,Cathy Flores,Ofelia Vargas-Shiraishi,Peter M Mourani,Kevin A Van,Avani Shukla,Jairo Chavez,Sabrina R Chen,Emily Jung,Mary K Dahmer,Chaandini Jayachandran,Lexie Goertzen,Brittany Faanes,Megan C Bledsoe,Shannon E Clark,Rachel L Wellman,Nicole Twinem,Amanda N Lansell,Rajashri Rasal,Maggie Flowers,Lisa Steele,Jenny L Bush,Ryan H Burnett,Debra Spear,Tricia L Lynch,Shoshona Le,Juliana DaSilva,Lisa Keong,Thomas Stark,Garten Kondor Rebecca,Wu Michael
DOI: https://doi.org/10.1093/cid/ciab931
2022-08-25
Abstract:Background: Predominance of 2 antigenically drifted influenza viruses during the 2019-2020 season offered an opportunity to assess vaccine effectiveness against life-threatening pediatric influenza disease from vaccine-mismatched viruses in the United States. Methods: We enrolled children aged <18 years admitted to the intensive care unit with acute respiratory infection across 17 hospitals. Respiratory specimens were tested using reverse-transcription polymerase chain reaction for influenza viruses and sequenced. Using a test-negative design, we estimated vaccine effectiveness comparing odds of vaccination in test-positive case patients vs test-negative controls, stratifying by age, virus type, and severity. Life-threating influenza included death or invasive mechanical ventilation, vasopressors, cardiopulmonary resuscitation, dialysis, or extracorporeal membrane oxygenation. Results: We enrolled 159 critically ill influenza case-patients (70% ≤8 years; 51% A/H1N1pdm09 and 25% B-Victoria viruses) and 132 controls (69% were aged ≤8 years). Among 56 sequenced A/H1N1pdm09 viruses, 29 (52%) were vaccine-mismatched (A/H1N1pdm09/5A+156K) and 23 (41%) were vaccine-matched (A/H1N1pdm09/5A+187A,189E). Among sequenced B-lineage viruses, majority (30 of 31) were vaccine-mismatched. Effectiveness against critical influenza was 63% (95% confidence interval [CI], 38% to 78%) and similar by age. Effectiveness was 75% (95% CI, 49% to 88%) against life-threatening influenza vs 57% (95% CI, 24% to 76%) against non-life-threating influenza. Effectiveness was 78% (95% CI, 41% to 92%) against matched A(H1N1)pdm09 viruses, 47% (95% CI, -21% to 77%) against mismatched A(H1N1)pdm09 viruses, and 75% (95% CI, 37% to 90%) against mismatched B-Victoria viruses. Conclusions: During a season when vaccine-mismatched influenza viruses predominated, vaccination was associated with a reduced risk of critical and life-threatening influenza illness in children.